nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP2C9—brain cancer	0.521	1	CbGaD
Delavirdine—CYP2D6—Lomustine—brain cancer	0.0594	0.187	CbGbCtD
Delavirdine—CYP1A2—Carmustine—brain cancer	0.0588	0.185	CbGbCtD
Delavirdine—CYP2D6—Hydroxyurea—brain cancer	0.045	0.142	CbGbCtD
Delavirdine—CYP3A4—Temozolomide—brain cancer	0.0444	0.14	CbGbCtD
Delavirdine—CYP3A4—Lomustine—brain cancer	0.0378	0.119	CbGbCtD
Delavirdine—CYP3A5—Etoposide—brain cancer	0.0234	0.0736	CbGbCtD
Delavirdine—CYP2C8—Etoposide—brain cancer	0.0225	0.0708	CbGbCtD
Delavirdine—CYP1A2—Etoposide—brain cancer	0.0174	0.0548	CbGbCtD
Delavirdine—CYP3A4—Etoposide—brain cancer	0.00913	0.0287	CbGbCtD
Delavirdine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00139	0.0513	CbGpPWpGaD
Delavirdine—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00125	0.0461	CbGpPWpGaD
Delavirdine—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00114	0.042	CbGpPWpGaD
Delavirdine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00112	0.0412	CbGpPWpGaD
Delavirdine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00102	0.0375	CbGpPWpGaD
Delavirdine—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00097	0.0357	CbGpPWpGaD
Delavirdine—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.000961	0.0354	CbGpPWpGaD
Delavirdine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000871	0.0321	CbGpPWpGaD
Delavirdine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000866	0.0319	CbGpPWpGaD
Delavirdine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000797	0.0293	CbGpPWpGaD
Delavirdine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000792	0.0292	CbGpPWpGaD
Delavirdine—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.000694	0.0256	CbGpPWpGaD
Delavirdine—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.000668	0.0246	CbGpPWpGaD
Delavirdine—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000601	0.0222	CbGpPWpGaD
Delavirdine—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000578	0.0213	CbGpPWpGaD
Delavirdine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000537	0.0198	CbGpPWpGaD
Delavirdine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000516	0.019	CbGpPWpGaD
Delavirdine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000494	0.0182	CbGpPWpGaD
Delavirdine—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000477	0.0176	CbGpPWpGaD
Delavirdine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000475	0.0175	CbGpPWpGaD
Delavirdine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000418	0.0154	CbGpPWpGaD
Delavirdine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000402	0.0148	CbGpPWpGaD
Delavirdine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000399	0.0147	CbGpPWpGaD
Delavirdine—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000394	0.0145	CbGpPWpGaD
Delavirdine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000369	0.0136	CbGpPWpGaD
Delavirdine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000323	0.0119	CbGpPWpGaD
Delavirdine—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000323	0.0119	CbGpPWpGaD
Delavirdine—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00031	0.0114	CbGpPWpGaD
Delavirdine—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000289	0.0106	CbGpPWpGaD
Delavirdine—Cardiac failure—Etoposide—brain cancer	0.000289	0.00215	CcSEcCtD
Delavirdine—Confusional state—Procarbazine—brain cancer	0.000289	0.00215	CcSEcCtD
Delavirdine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000288	0.0106	CbGpPWpGaD
Delavirdine—Vomiting—Lomustine—brain cancer	0.000287	0.00213	CcSEcCtD
Delavirdine—Oedema—Procarbazine—brain cancer	0.000286	0.00213	CcSEcCtD
Delavirdine—Neutropenia—Temozolomide—brain cancer	0.000285	0.00212	CcSEcCtD
Delavirdine—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000285	0.0105	CbGpPWpGaD
Delavirdine—Infection—Procarbazine—brain cancer	0.000284	0.00212	CcSEcCtD
Delavirdine—Hyperglycaemia—Carmustine—brain cancer	0.000284	0.00211	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Temozolomide—brain cancer	0.000283	0.0021	CcSEcCtD
Delavirdine—Pneumonia—Carmustine—brain cancer	0.000282	0.0021	CcSEcCtD
Delavirdine—Shock—Procarbazine—brain cancer	0.000282	0.0021	CcSEcCtD
Delavirdine—Erectile dysfunction—Temozolomide—brain cancer	0.00028	0.00209	CcSEcCtD
Delavirdine—Thrombocytopenia—Procarbazine—brain cancer	0.00028	0.00209	CcSEcCtD
Delavirdine—Chills—Hydroxyurea—brain cancer	0.00028	0.00208	CcSEcCtD
Delavirdine—Tachycardia—Procarbazine—brain cancer	0.000279	0.00208	CcSEcCtD
Delavirdine—Weight increased—Temozolomide—brain cancer	0.000277	0.00206	CcSEcCtD
Delavirdine—Hyperhidrosis—Procarbazine—brain cancer	0.000277	0.00206	CcSEcCtD
Delavirdine—Alopecia—Hydroxyurea—brain cancer	0.000276	0.00205	CcSEcCtD
Delavirdine—Neuropathy peripheral—Carmustine—brain cancer	0.000275	0.00205	CcSEcCtD
Delavirdine—Hyperglycaemia—Temozolomide—brain cancer	0.000275	0.00204	CcSEcCtD
Delavirdine—Stomatitis—Carmustine—brain cancer	0.000274	0.00204	CcSEcCtD
Delavirdine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000274	0.0101	CbGpPWpGaD
Delavirdine—Urinary tract infection—Carmustine—brain cancer	0.000273	0.00203	CcSEcCtD
Delavirdine—Pneumonia—Temozolomide—brain cancer	0.000273	0.00203	CcSEcCtD
Delavirdine—Anorexia—Procarbazine—brain cancer	0.000273	0.00203	CcSEcCtD
Delavirdine—Erythema—Hydroxyurea—brain cancer	0.000271	0.00202	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000269	0.002	CcSEcCtD
Delavirdine—Nausea—Lomustine—brain cancer	0.000268	0.00199	CcSEcCtD
Delavirdine—Hypotension—Procarbazine—brain cancer	0.000267	0.00199	CcSEcCtD
Delavirdine—Neuropathy peripheral—Temozolomide—brain cancer	0.000266	0.00198	CcSEcCtD
Delavirdine—Stomatitis—Temozolomide—brain cancer	0.000265	0.00197	CcSEcCtD
Delavirdine—Urinary tract infection—Temozolomide—brain cancer	0.000264	0.00196	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000261	0.00194	CcSEcCtD
Delavirdine—Insomnia—Procarbazine—brain cancer	0.000259	0.00193	CcSEcCtD
Delavirdine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000258	0.0095	CbGpPWpGaD
Delavirdine—Paraesthesia—Procarbazine—brain cancer	0.000257	0.00191	CcSEcCtD
Delavirdine—Sinusitis—Temozolomide—brain cancer	0.000255	0.00189	CcSEcCtD
Delavirdine—Somnolence—Procarbazine—brain cancer	0.000254	0.00189	CcSEcCtD
Delavirdine—Cramp muscle—Etoposide—brain cancer	0.000254	0.00189	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000254	0.00189	CcSEcCtD
Delavirdine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000252	0.00187	CcSEcCtD
Delavirdine—Anaemia—Hydroxyurea—brain cancer	0.000251	0.00187	CcSEcCtD
Delavirdine—Hypoaesthesia—Carmustine—brain cancer	0.000251	0.00187	CcSEcCtD
Delavirdine—Hallucination—Carmustine—brain cancer	0.000251	0.00187	CcSEcCtD
Delavirdine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00025	0.0092	CbGpPWpGaD
Delavirdine—Decreased appetite—Procarbazine—brain cancer	0.000249	0.00185	CcSEcCtD
Delavirdine—Oedema peripheral—Carmustine—brain cancer	0.000248	0.00185	CcSEcCtD
Delavirdine—Fatigue—Procarbazine—brain cancer	0.000247	0.00184	CcSEcCtD
Delavirdine—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000246	0.00908	CbGpPWpGaD
Delavirdine—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000245	0.00902	CbGpPWpGaD
Delavirdine—Malaise—Hydroxyurea—brain cancer	0.000245	0.00182	CcSEcCtD
Delavirdine—Pain—Procarbazine—brain cancer	0.000245	0.00182	CcSEcCtD
Delavirdine—Constipation—Procarbazine—brain cancer	0.000245	0.00182	CcSEcCtD
Delavirdine—Hepatitis—Temozolomide—brain cancer	0.000244	0.00181	CcSEcCtD
Delavirdine—Dysphagia—Etoposide—brain cancer	0.000244	0.00181	CcSEcCtD
Delavirdine—Leukopenia—Hydroxyurea—brain cancer	0.000243	0.00181	CcSEcCtD
Delavirdine—Hallucination—Temozolomide—brain cancer	0.000242	0.0018	CcSEcCtD
Delavirdine—Hypoaesthesia—Temozolomide—brain cancer	0.000242	0.0018	CcSEcCtD
Delavirdine—Pharyngitis—Temozolomide—brain cancer	0.000242	0.0018	CcSEcCtD
Delavirdine—Oedema peripheral—Temozolomide—brain cancer	0.00024	0.00179	CcSEcCtD
Delavirdine—Sweating increased—Etoposide—brain cancer	0.000237	0.00176	CcSEcCtD
Delavirdine—Feeling abnormal—Procarbazine—brain cancer	0.000236	0.00175	CcSEcCtD
Delavirdine—Gastrointestinal pain—Procarbazine—brain cancer	0.000234	0.00174	CcSEcCtD
Delavirdine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000234	0.00861	CbGpPWpGaD
Delavirdine—Pancytopenia—Etoposide—brain cancer	0.000231	0.00172	CcSEcCtD
Delavirdine—Erythema multiforme—Temozolomide—brain cancer	0.00023	0.00171	CcSEcCtD
Delavirdine—Discomfort—Hydroxyurea—brain cancer	0.000228	0.0017	CcSEcCtD
Delavirdine—Neutropenia—Etoposide—brain cancer	0.000228	0.00169	CcSEcCtD
Delavirdine—Urticaria—Procarbazine—brain cancer	0.000227	0.00169	CcSEcCtD
Delavirdine—Tinnitus—Temozolomide—brain cancer	0.000227	0.00169	CcSEcCtD
Delavirdine—Body temperature increased—Procarbazine—brain cancer	0.000226	0.00168	CcSEcCtD
Delavirdine—Abdominal pain—Procarbazine—brain cancer	0.000226	0.00168	CcSEcCtD
Delavirdine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000223	0.00821	CbGpPWpGaD
Delavirdine—Alopecia—Carmustine—brain cancer	0.000223	0.00166	CcSEcCtD
Delavirdine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000222	0.00816	CbGpPWpGaD
Delavirdine—Oedema—Hydroxyurea—brain cancer	0.000222	0.00165	CcSEcCtD
Delavirdine—Infection—Hydroxyurea—brain cancer	0.00022	0.00164	CcSEcCtD
Delavirdine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00022	0.0081	CbGpPWpGaD
Delavirdine—Malnutrition—Carmustine—brain cancer	0.000219	0.00163	CcSEcCtD
Delavirdine—Erythema—Carmustine—brain cancer	0.000219	0.00163	CcSEcCtD
Delavirdine—Chills—Temozolomide—brain cancer	0.000219	0.00163	CcSEcCtD
Delavirdine—Pneumonia—Etoposide—brain cancer	0.000218	0.00162	CcSEcCtD
Delavirdine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000217	0.00161	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000215	0.0016	CcSEcCtD
Delavirdine—Alopecia—Temozolomide—brain cancer	0.000215	0.0016	CcSEcCtD
Delavirdine—Skin disorder—Hydroxyurea—brain cancer	0.000215	0.0016	CcSEcCtD
Delavirdine—Neuropathy peripheral—Etoposide—brain cancer	0.000213	0.00158	CcSEcCtD
Delavirdine—Back pain—Carmustine—brain cancer	0.000212	0.00158	CcSEcCtD
Delavirdine—Malnutrition—Temozolomide—brain cancer	0.000212	0.00158	CcSEcCtD
Delavirdine—Erythema—Temozolomide—brain cancer	0.000212	0.00158	CcSEcCtD
Delavirdine—Stomatitis—Etoposide—brain cancer	0.000212	0.00157	CcSEcCtD
Delavirdine—Jaundice—Etoposide—brain cancer	0.000212	0.00157	CcSEcCtD
Delavirdine—Anorexia—Hydroxyurea—brain cancer	0.000211	0.00157	CcSEcCtD
Delavirdine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000211	0.00778	CbGpPWpGaD
Delavirdine—Hypersensitivity—Procarbazine—brain cancer	0.000211	0.00157	CcSEcCtD
Delavirdine—Dysgeusia—Temozolomide—brain cancer	0.000208	0.00154	CcSEcCtD
Delavirdine—Vision blurred—Carmustine—brain cancer	0.000207	0.00154	CcSEcCtD
Delavirdine—Tremor—Carmustine—brain cancer	0.000206	0.00153	CcSEcCtD
Delavirdine—Asthenia—Procarbazine—brain cancer	0.000205	0.00153	CcSEcCtD
Delavirdine—Back pain—Temozolomide—brain cancer	0.000205	0.00153	CcSEcCtD
Delavirdine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000205	0.00755	CbGpPWpGaD
Delavirdine—Anaemia—Carmustine—brain cancer	0.000203	0.00151	CcSEcCtD
Delavirdine—Pruritus—Procarbazine—brain cancer	0.000203	0.00151	CcSEcCtD
Delavirdine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000202	0.00746	CbGpPWpGaD
Delavirdine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000202	0.00745	CbGpPWpGaD
Delavirdine—Agitation—Carmustine—brain cancer	0.000202	0.0015	CcSEcCtD
Delavirdine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000201	0.0074	CbGpPWpGaD
Delavirdine—Vision blurred—Temozolomide—brain cancer	0.0002	0.00149	CcSEcCtD
Delavirdine—Tremor—Temozolomide—brain cancer	0.000199	0.00148	CcSEcCtD
Delavirdine—Dyspnoea—Hydroxyurea—brain cancer	0.000198	0.00147	CcSEcCtD
Delavirdine—Somnolence—Hydroxyurea—brain cancer	0.000197	0.00147	CcSEcCtD
Delavirdine—Ill-defined disorder—Temozolomide—brain cancer	0.000197	0.00146	CcSEcCtD
Delavirdine—Leukopenia—Carmustine—brain cancer	0.000196	0.00146	CcSEcCtD
Delavirdine—Anaemia—Temozolomide—brain cancer	0.000196	0.00146	CcSEcCtD
Delavirdine—Diarrhoea—Procarbazine—brain cancer	0.000196	0.00146	CcSEcCtD
Delavirdine—Dyspepsia—Hydroxyurea—brain cancer	0.000195	0.00145	CcSEcCtD
Delavirdine—Agitation—Temozolomide—brain cancer	0.000195	0.00145	CcSEcCtD
Delavirdine—Hypoaesthesia—Etoposide—brain cancer	0.000194	0.00144	CcSEcCtD
Delavirdine—Angioedema—Temozolomide—brain cancer	0.000194	0.00144	CcSEcCtD
Delavirdine—Decreased appetite—Hydroxyurea—brain cancer	0.000193	0.00143	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000191	0.00142	CcSEcCtD
Delavirdine—Malaise—Temozolomide—brain cancer	0.000191	0.00142	CcSEcCtD
Delavirdine—Fatigue—Hydroxyurea—brain cancer	0.000191	0.00142	CcSEcCtD
Delavirdine—Vertigo—Temozolomide—brain cancer	0.000191	0.00142	CcSEcCtD
Delavirdine—Leukopenia—Temozolomide—brain cancer	0.00019	0.00141	CcSEcCtD
Delavirdine—Hypertension—Carmustine—brain cancer	0.000189	0.00141	CcSEcCtD
Delavirdine—Constipation—Hydroxyurea—brain cancer	0.000189	0.00141	CcSEcCtD
Delavirdine—Pain—Hydroxyurea—brain cancer	0.000189	0.00141	CcSEcCtD
Delavirdine—Dizziness—Procarbazine—brain cancer	0.000189	0.00141	CcSEcCtD
Delavirdine—Palpitations—Temozolomide—brain cancer	0.000187	0.00139	CcSEcCtD
Delavirdine—Myalgia—Carmustine—brain cancer	0.000187	0.00139	CcSEcCtD
Delavirdine—Chest pain—Carmustine—brain cancer	0.000187	0.00139	CcSEcCtD
Delavirdine—Anxiety—Carmustine—brain cancer	0.000186	0.00139	CcSEcCtD
Delavirdine—Cough—Temozolomide—brain cancer	0.000185	0.00138	CcSEcCtD
Delavirdine—Erythema multiforme—Etoposide—brain cancer	0.000184	0.00137	CcSEcCtD
Delavirdine—Hypertension—Temozolomide—brain cancer	0.000183	0.00136	CcSEcCtD
Delavirdine—Feeling abnormal—Hydroxyurea—brain cancer	0.000183	0.00136	CcSEcCtD
Delavirdine—Vomiting—Procarbazine—brain cancer	0.000182	0.00135	CcSEcCtD
Delavirdine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000181	0.00666	CbGpPWpGaD
Delavirdine—Confusional state—Carmustine—brain cancer	0.000181	0.00134	CcSEcCtD
Delavirdine—Myalgia—Temozolomide—brain cancer	0.000181	0.00134	CcSEcCtD
Delavirdine—Arthralgia—Temozolomide—brain cancer	0.000181	0.00134	CcSEcCtD
Delavirdine—Rash—Procarbazine—brain cancer	0.00018	0.00134	CcSEcCtD
Delavirdine—Dermatitis—Procarbazine—brain cancer	0.00018	0.00134	CcSEcCtD
Delavirdine—Anxiety—Temozolomide—brain cancer	0.00018	0.00134	CcSEcCtD
Delavirdine—Headache—Procarbazine—brain cancer	0.000179	0.00133	CcSEcCtD
Delavirdine—Oedema—Carmustine—brain cancer	0.000179	0.00133	CcSEcCtD
Delavirdine—Discomfort—Temozolomide—brain cancer	0.000178	0.00133	CcSEcCtD
Delavirdine—Infection—Carmustine—brain cancer	0.000178	0.00132	CcSEcCtD
Delavirdine—Dry mouth—Temozolomide—brain cancer	0.000177	0.00131	CcSEcCtD
Delavirdine—Thrombocytopenia—Carmustine—brain cancer	0.000175	0.0013	CcSEcCtD
Delavirdine—Body temperature increased—Hydroxyurea—brain cancer	0.000175	0.0013	CcSEcCtD
Delavirdine—Chills—Etoposide—brain cancer	0.000175	0.0013	CcSEcCtD
Delavirdine—Tachycardia—Carmustine—brain cancer	0.000175	0.0013	CcSEcCtD
Delavirdine—Confusional state—Temozolomide—brain cancer	0.000175	0.0013	CcSEcCtD
Delavirdine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000174	0.0064	CbGpPWpGaD
Delavirdine—Oedema—Temozolomide—brain cancer	0.000173	0.00129	CcSEcCtD
Delavirdine—Alopecia—Etoposide—brain cancer	0.000172	0.00128	CcSEcCtD
Delavirdine—Infection—Temozolomide—brain cancer	0.000172	0.00128	CcSEcCtD
Delavirdine—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000172	0.00633	CbGpPWpGaD
Delavirdine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000171	0.00631	CbGpPWpGaD
Delavirdine—Anorexia—Carmustine—brain cancer	0.000171	0.00127	CcSEcCtD
Delavirdine—Nausea—Procarbazine—brain cancer	0.00017	0.00127	CcSEcCtD
Delavirdine—Thrombocytopenia—Temozolomide—brain cancer	0.000169	0.00126	CcSEcCtD
Delavirdine—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000169	0.00624	CbGpPWpGaD
Delavirdine—Skin disorder—Temozolomide—brain cancer	0.000168	0.00125	CcSEcCtD
Delavirdine—Hypotension—Carmustine—brain cancer	0.000167	0.00125	CcSEcCtD
Delavirdine—Hyperhidrosis—Temozolomide—brain cancer	0.000167	0.00124	CcSEcCtD
Delavirdine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000166	0.00612	CbGpPWpGaD
Delavirdine—Dysgeusia—Etoposide—brain cancer	0.000166	0.00124	CcSEcCtD
Delavirdine—Anorexia—Temozolomide—brain cancer	0.000165	0.00123	CcSEcCtD
Delavirdine—Back pain—Etoposide—brain cancer	0.000164	0.00122	CcSEcCtD
Delavirdine—Hypersensitivity—Hydroxyurea—brain cancer	0.000163	0.00121	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000163	0.00121	CcSEcCtD
Delavirdine—Muscle spasms—Etoposide—brain cancer	0.000163	0.00121	CcSEcCtD
Delavirdine—Insomnia—Carmustine—brain cancer	0.000162	0.00121	CcSEcCtD
Delavirdine—Paraesthesia—Carmustine—brain cancer	0.000161	0.0012	CcSEcCtD
Delavirdine—Dyspnoea—Carmustine—brain cancer	0.00016	0.00119	CcSEcCtD
Delavirdine—Somnolence—Carmustine—brain cancer	0.000159	0.00118	CcSEcCtD
Delavirdine—Asthenia—Hydroxyurea—brain cancer	0.000159	0.00118	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000158	0.00117	CcSEcCtD
Delavirdine—Ill-defined disorder—Etoposide—brain cancer	0.000157	0.00117	CcSEcCtD
Delavirdine—Anaemia—Etoposide—brain cancer	0.000157	0.00117	CcSEcCtD
Delavirdine—Insomnia—Temozolomide—brain cancer	0.000157	0.00116	CcSEcCtD
Delavirdine—Decreased appetite—Carmustine—brain cancer	0.000156	0.00116	CcSEcCtD
Delavirdine—Paraesthesia—Temozolomide—brain cancer	0.000155	0.00116	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Carmustine—brain cancer	0.000155	0.00115	CcSEcCtD
Delavirdine—Dyspnoea—Temozolomide—brain cancer	0.000154	0.00115	CcSEcCtD
Delavirdine—Somnolence—Temozolomide—brain cancer	0.000154	0.00114	CcSEcCtD
Delavirdine—Pain—Carmustine—brain cancer	0.000153	0.00114	CcSEcCtD
Delavirdine—Constipation—Carmustine—brain cancer	0.000153	0.00114	CcSEcCtD
Delavirdine—Malaise—Etoposide—brain cancer	0.000153	0.00114	CcSEcCtD
Delavirdine—Vertigo—Etoposide—brain cancer	0.000152	0.00113	CcSEcCtD
Delavirdine—Dyspepsia—Temozolomide—brain cancer	0.000152	0.00113	CcSEcCtD
Delavirdine—Leukopenia—Etoposide—brain cancer	0.000152	0.00113	CcSEcCtD
Delavirdine—Diarrhoea—Hydroxyurea—brain cancer	0.000152	0.00113	CcSEcCtD
Delavirdine—Decreased appetite—Temozolomide—brain cancer	0.00015	0.00112	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000149	0.00111	CcSEcCtD
Delavirdine—Fatigue—Temozolomide—brain cancer	0.000149	0.00111	CcSEcCtD
Delavirdine—Loss of consciousness—Etoposide—brain cancer	0.000149	0.00111	CcSEcCtD
Delavirdine—Cough—Etoposide—brain cancer	0.000148	0.0011	CcSEcCtD
Delavirdine—Pain—Temozolomide—brain cancer	0.000148	0.0011	CcSEcCtD
Delavirdine—Constipation—Temozolomide—brain cancer	0.000148	0.0011	CcSEcCtD
Delavirdine—Feeling abnormal—Carmustine—brain cancer	0.000148	0.0011	CcSEcCtD
Delavirdine—Hypertension—Etoposide—brain cancer	0.000147	0.00109	CcSEcCtD
Delavirdine—Dizziness—Hydroxyurea—brain cancer	0.000146	0.00109	CcSEcCtD
Delavirdine—Gastrointestinal pain—Carmustine—brain cancer	0.000146	0.00109	CcSEcCtD
Delavirdine—Chest pain—Etoposide—brain cancer	0.000144	0.00107	CcSEcCtD
Delavirdine—Discomfort—Etoposide—brain cancer	0.000143	0.00106	CcSEcCtD
Delavirdine—Feeling abnormal—Temozolomide—brain cancer	0.000143	0.00106	CcSEcCtD
Delavirdine—Abdominal pain—Carmustine—brain cancer	0.000142	0.00105	CcSEcCtD
Delavirdine—Body temperature increased—Carmustine—brain cancer	0.000142	0.00105	CcSEcCtD
Delavirdine—Gastrointestinal pain—Temozolomide—brain cancer	0.000142	0.00105	CcSEcCtD
Delavirdine—Vomiting—Hydroxyurea—brain cancer	0.000141	0.00105	CcSEcCtD
Delavirdine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000141	0.00519	CbGpPWpGaD
Delavirdine—Rash—Hydroxyurea—brain cancer	0.00014	0.00104	CcSEcCtD
Delavirdine—Confusional state—Etoposide—brain cancer	0.00014	0.00104	CcSEcCtD
Delavirdine—Dermatitis—Hydroxyurea—brain cancer	0.00014	0.00104	CcSEcCtD
Delavirdine—Headache—Hydroxyurea—brain cancer	0.000139	0.00103	CcSEcCtD
Delavirdine—Infection—Etoposide—brain cancer	0.000138	0.00102	CcSEcCtD
Delavirdine—Urticaria—Temozolomide—brain cancer	0.000137	0.00102	CcSEcCtD
Delavirdine—Abdominal pain—Temozolomide—brain cancer	0.000137	0.00102	CcSEcCtD
Delavirdine—Body temperature increased—Temozolomide—brain cancer	0.000137	0.00102	CcSEcCtD
Delavirdine—Thrombocytopenia—Etoposide—brain cancer	0.000136	0.00101	CcSEcCtD
Delavirdine—Tachycardia—Etoposide—brain cancer	0.000135	0.00101	CcSEcCtD
Delavirdine—Skin disorder—Etoposide—brain cancer	0.000135	0.001	CcSEcCtD
Delavirdine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.00494	CbGpPWpGaD
Delavirdine—Hyperhidrosis—Etoposide—brain cancer	0.000134	0.000996	CcSEcCtD
Delavirdine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000132	0.00487	CbGpPWpGaD
Delavirdine—Anorexia—Etoposide—brain cancer	0.000132	0.000982	CcSEcCtD
Delavirdine—Hypersensitivity—Carmustine—brain cancer	0.000132	0.000982	CcSEcCtD
Delavirdine—Nausea—Hydroxyurea—brain cancer	0.000132	0.000979	CcSEcCtD
Delavirdine—Hypotension—Etoposide—brain cancer	0.000129	0.000963	CcSEcCtD
Delavirdine—Asthenia—Carmustine—brain cancer	0.000128	0.000956	CcSEcCtD
Delavirdine—Hypersensitivity—Temozolomide—brain cancer	0.000128	0.000949	CcSEcCtD
Delavirdine—Paraesthesia—Etoposide—brain cancer	0.000124	0.000925	CcSEcCtD
Delavirdine—Asthenia—Temozolomide—brain cancer	0.000124	0.000924	CcSEcCtD
Delavirdine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000124	0.00457	CbGpPWpGaD
Delavirdine—Dyspnoea—Etoposide—brain cancer	0.000123	0.000919	CcSEcCtD
Delavirdine—Somnolence—Etoposide—brain cancer	0.000123	0.000916	CcSEcCtD
Delavirdine—Diarrhoea—Carmustine—brain cancer	0.000123	0.000912	CcSEcCtD
Delavirdine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000122	0.00451	CbGpPWpGaD
Delavirdine—Pruritus—Temozolomide—brain cancer	0.000122	0.000911	CcSEcCtD
Delavirdine—Decreased appetite—Etoposide—brain cancer	0.00012	0.000896	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Etoposide—brain cancer	0.00012	0.00089	CcSEcCtD
Delavirdine—Fatigue—Etoposide—brain cancer	0.000119	0.000888	CcSEcCtD
Delavirdine—Dizziness—Carmustine—brain cancer	0.000118	0.000881	CcSEcCtD
Delavirdine—Pain—Etoposide—brain cancer	0.000118	0.000881	CcSEcCtD
Delavirdine—Constipation—Etoposide—brain cancer	0.000118	0.000881	CcSEcCtD
Delavirdine—Diarrhoea—Temozolomide—brain cancer	0.000118	0.000881	CcSEcCtD
Delavirdine—Dizziness—Temozolomide—brain cancer	0.000114	0.000851	CcSEcCtD
Delavirdine—Feeling abnormal—Etoposide—brain cancer	0.000114	0.000849	CcSEcCtD
Delavirdine—Vomiting—Carmustine—brain cancer	0.000114	0.000847	CcSEcCtD
Delavirdine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000114	0.00419	CbGpPWpGaD
Delavirdine—Gastrointestinal pain—Etoposide—brain cancer	0.000113	0.000843	CcSEcCtD
Delavirdine—Rash—Carmustine—brain cancer	0.000113	0.00084	CcSEcCtD
Delavirdine—Dermatitis—Carmustine—brain cancer	0.000113	0.000839	CcSEcCtD
Delavirdine—Headache—Carmustine—brain cancer	0.000112	0.000835	CcSEcCtD
Delavirdine—Vomiting—Temozolomide—brain cancer	0.00011	0.000819	CcSEcCtD
Delavirdine—Urticaria—Etoposide—brain cancer	0.00011	0.000819	CcSEcCtD
Delavirdine—Abdominal pain—Etoposide—brain cancer	0.000109	0.000815	CcSEcCtD
Delavirdine—Body temperature increased—Etoposide—brain cancer	0.000109	0.000815	CcSEcCtD
Delavirdine—Rash—Temozolomide—brain cancer	0.000109	0.000812	CcSEcCtD
Delavirdine—Dermatitis—Temozolomide—brain cancer	0.000109	0.000811	CcSEcCtD
Delavirdine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.004	CbGpPWpGaD
Delavirdine—Headache—Temozolomide—brain cancer	0.000108	0.000807	CcSEcCtD
Delavirdine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000108	0.00396	CbGpPWpGaD
Delavirdine—Nausea—Carmustine—brain cancer	0.000106	0.000791	CcSEcCtD
Delavirdine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00391	CbGpPWpGaD
Delavirdine—Nausea—Temozolomide—brain cancer	0.000103	0.000765	CcSEcCtD
Delavirdine—Hypersensitivity—Etoposide—brain cancer	0.000102	0.000759	CcSEcCtD
Delavirdine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000101	0.00372	CbGpPWpGaD
Delavirdine—Asthenia—Etoposide—brain cancer	9.94e-05	0.000739	CcSEcCtD
Delavirdine—Pruritus—Etoposide—brain cancer	9.8e-05	0.000729	CcSEcCtD
Delavirdine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.6e-05	0.00354	CbGpPWpGaD
Delavirdine—Diarrhoea—Etoposide—brain cancer	9.48e-05	0.000705	CcSEcCtD
Delavirdine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.47e-05	0.00349	CbGpPWpGaD
Delavirdine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.27e-05	0.00341	CbGpPWpGaD
Delavirdine—Dizziness—Etoposide—brain cancer	9.16e-05	0.000681	CcSEcCtD
Delavirdine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.83e-05	0.00325	CbGpPWpGaD
Delavirdine—Vomiting—Etoposide—brain cancer	8.81e-05	0.000655	CcSEcCtD
Delavirdine—Rash—Etoposide—brain cancer	8.73e-05	0.00065	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—brain cancer	8.72e-05	0.000649	CcSEcCtD
Delavirdine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.71e-05	0.00321	CbGpPWpGaD
Delavirdine—Headache—Etoposide—brain cancer	8.68e-05	0.000645	CcSEcCtD
Delavirdine—Nausea—Etoposide—brain cancer	8.23e-05	0.000612	CcSEcCtD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.71e-05	0.00284	CbGpPWpGaD
Delavirdine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.48e-05	0.00275	CbGpPWpGaD
Delavirdine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.38e-05	0.00272	CbGpPWpGaD
Delavirdine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.77e-05	0.00213	CbGpPWpGaD
Delavirdine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.69e-05	0.0021	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.45e-05	0.00164	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.13e-05	0.00152	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.01e-05	0.00148	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.69e-05	0.00136	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.41e-05	0.00125	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.13e-05	0.00115	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.07e-05	0.00113	CbGpPWpGaD
Delavirdine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.07e-05	0.00113	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.02e-05	0.00111	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—CYP2C9—brain cancer	2.94e-05	0.00108	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.87e-05	0.00106	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.7e-05	0.000993	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—BSG—brain cancer	2.5e-05	0.00092	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.46e-05	0.000905	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—IDH1—brain cancer	2.15e-05	0.000791	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—CYP2C9—brain cancer	2.12e-05	0.000782	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.1e-05	0.000774	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000677	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—BSG—brain cancer	1.81e-05	0.000665	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—ENO2—brain cancer	1.7e-05	0.000625	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000605	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—BSG—brain cancer	1.56e-05	0.000576	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—IDH1—brain cancer	1.55e-05	0.000572	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000556	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—BSG—brain cancer	1.4e-05	0.000514	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—IDH1—brain cancer	1.34e-05	0.000495	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—BSG—brain cancer	1.28e-05	0.000473	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000471	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—BSG—brain cancer	1.27e-05	0.000469	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—ENO2—brain cancer	1.23e-05	0.000452	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—IDH1—brain cancer	1.2e-05	0.000442	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—IDH1—brain cancer	1.1e-05	0.000407	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.09e-05	0.000403	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—IDH1—brain cancer	1.09e-05	0.000403	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—BSG—brain cancer	1.09e-05	0.000401	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—ENO2—brain cancer	1.06e-05	0.000392	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—CYP2C9—brain cancer	9.87e-06	0.000364	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.77e-06	0.00036	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—ENO2—brain cancer	9.49e-06	0.000349	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—IDH1—brain cancer	9.35e-06	0.000344	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.91e-06	0.000328	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—ENO2—brain cancer	8.73e-06	0.000321	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—ENO2—brain cancer	8.65e-06	0.000319	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—BSG—brain cancer	8.39e-06	0.000309	CbGpPWpGaD
Delavirdine—CYP3A7—Metabolism—PIK3CG—brain cancer	7.79e-06	0.000287	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.61e-06	0.00028	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—ENO2—brain cancer	7.39e-06	0.000272	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—IDH1—brain cancer	7.22e-06	0.000266	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—ENO2—brain cancer	5.71e-06	0.00021	CbGpPWpGaD
Delavirdine—CYP3A5—Metabolism—PIK3CG—brain cancer	5.63e-06	0.000207	CbGpPWpGaD
Delavirdine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.88e-06	0.00018	CbGpPWpGaD
Delavirdine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.35e-06	0.00016	CbGpPWpGaD
Delavirdine—CYP2D6—Metabolism—PIK3CG—brain cancer	4e-06	0.000147	CbGpPWpGaD
Delavirdine—CYP2C9—Metabolism—PIK3CG—brain cancer	3.97e-06	0.000146	CbGpPWpGaD
Delavirdine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.39e-06	0.000125	CbGpPWpGaD
Delavirdine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.62e-06	9.64e-05	CbGpPWpGaD
